Fundraising Fox

Aptimmune Biologics

Champaign, US · Illinois corporation · 5 known investors

aptimmune.com ↗

Aptimmune Biologics develops vaccine platform technologies targeting swine diseases including PRRSV, swine influenza, and African swine fever, serving livestock producers and vaccine markets globally.

Biotech@aptimmune

Founders & leadership

RE
Robert EasterDirector
PO
Paul OlivoDirector
AG
Aaron GilbertieExecutive Officer, Director
GD
Gary DurackDirector
FZ
Federico ZuckermannExecutive Officer, Director

Investors · 5

Illinois VenturesChampaign
Missouri Technology CorporationSt. Louis
The Yield Lab Asia PacificSingapore
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
The Yield LabreportedSingapore · $48K – $12M

Reported raises · per SEC filings

Form D private placements
▶$2.2MraisedJul 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul OlivoDirector
  • Aaron GilbertieExecutive Officer, Director
  • Gary DurackDirector
  • Robert EasterDirector
  • Federico ZuckermannExecutive Officer, Director
Offering amount
$7M
Amount sold
$2.2M
Minimum investment
$80K
Proceeds to insiders
$400K
First sale
Jun 2017
Incorporated
Corporation, Illinois
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedMar 2016 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert EasterDirector
  • Paul OlivoDirector
  • Aaron GilbertieExecutive Officer, Director
  • Gary DurackDirector
  • Federico ZuckermannExecutive Officer, Director
Offering amount
$3.3M
Amount sold
$2.4M
Minimum investment
$1
Proceeds to insiders
$432K
First sale
Jun 2015
Incorporated
Corporation, Illinois
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.